Appoints new physician leaders
LOUISVILLE, Ky. (Oct. 11, 2012) — KentuckyOne Health announced today that it will invest an additional $30 million in its KentuckyOne Heart and Vascular Institute over the next three years. KentuckyOne already has invested more than $100 million over the past 10 years bringing the total investment to more than $130 million during that time.
KentuckyOne Health treats more heart patients than any other health system in the state of Kentucky and has performed many firsts in heart care in Louisville, Lexington, the region, state and world, including being the first hospital in the Louisville area to perform a Syncardia total artificial heart implant.
[pullquote_left]“We want to save more lives than ever before by investing in technology and resources to provide heart and vascular care across the commonwealth, including to individuals in their own hometowns and communities.” — Ruth Brinkley, president and CEO of KentuckyOne Health[/pullquote_left]
Kentucky has some of the nation’s highest rates of cancer, obesity and death because of heart disease and stroke.
“Too many Kentuckians are at risk for heart attack or stroke,” said Ruth Brinkley, president and CEO of KentuckyOne Health. “We want to save more lives than ever before by investing in technology and resources to provide heart and vascular care across the commonwealth, including to individuals in their own hometowns and communities.”
Plans for the additional $30 million include investments in outreach, collaboration, technologies and programs.
“With KentuckyOne’s development of virtual/remote consultation clinics across the state of Kentucky, doctors can provide care to patients with heart disease closer to their homes,” said Dr. Mark Slaughter, newly appointed executive director of cardiovascular services for the KentuckyOne Health Louisville market. “I am honored to be named the new executive director of their Louisville market Cardiovascular Services and to be here at a time when this leading heart center is making additional investments and expansion in a number of programs like our Transcatheter Aortic-Valve Replacement (TAVR), Imaging, Arrhythmia and Peripheral Vascular Disease programs.”
“An expansion of the Hybrid Operating Room technology and a dedicated Cardiac Resuscitation Center will also give patients access to more unique and specialized services,” added Slaughter, who also is the director of the Division of Thoracic and Cardiovascular Surgery at the University of Louisville.